IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Stopped Because of approval of Bevacizumab, it was difficult to perform clinical study in 1st line setting.
Conditions
- Metastatic Colorectal Cancer
Interventions
- DRUG: Campto, Topotesin
- DRUG: TS-1
- DRUG: L-Plat
- DRUG: Isovorin
- DRUG: 5-FU
Sponsor
Hokkaido Gastrointestinal Cancer Study Group
Collaborators